Home
/
ENDRA Life Sciences Inc.
/
Financials
/
Quarterly
ENDRA Life Sciences Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ENDRA Life Sciences Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2019
Sep 30, 2019
$0
Nov 13, 2019
Q2
2019
Jun 30, 2019
$0
Aug 8, 2019
Q1
2019
Mar 31, 2019
$0
May 14, 2019
Q3
2019
Sep 30, 2018
$0
Nov 13, 2019
Q2
2019
Jun 30, 2018
$0
Aug 8, 2019
Q1
2019
Mar 31, 2018
$6.2K
May 14, 2019
Q3
2018
Sep 30, 2017
$287.0K
Nov 5, 2018
Q2
2018
Jun 30, 2017
$57.8K
Aug 13, 2018
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$6.2K
May 15, 2018
Q3
2017
Sep 30, 2017
$287.0K
Nov 14, 2017
Q2
2017
Jun 30, 2017
$57.8K
Aug 7, 2017
Q1
2018
Mar 31, 2017
$0
May 15, 2018
Q3
2017
Sep 30, 2016
$0
Nov 14, 2017
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.60M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($1.23M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.04M)
May 15, 2025
Q3
2025
Sep 30, 2024
($2.35M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($2.23M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($2.78M)
May 15, 2025
Q3
2024
Sep 30, 2023
($3.10M)
Nov 21, 2024
Q2
2024
Jun 30, 2023
($2.56M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($2.94M)
May 14, 2024
Q3
2023
Sep 30, 2022
($3.44M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($3.59M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($2.86M)
May 15, 2023
Q3
2022
Sep 30, 2021
($2.66M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($3.20M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($2.27M)
May 12, 2022
Q3
2021
Sep 30, 2020
($3.26M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($2.89M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($3.32M)
May 17, 2021
Q3
2020
Sep 30, 2019
($3.41M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($2.33M)
Aug 14, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.37M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($1.30M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.47M)
May 15, 2025
Q3
2025
Sep 30, 2024
($1.51M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($2.23M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($2.78M)
May 15, 2025
Q3
2024
Sep 30, 2023
($3.13M)
Nov 21, 2024
Q2
2024
Jun 30, 2023
($2.99M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($2.94M)
May 14, 2024
Q3
2023
Sep 30, 2022
($3.42M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($3.57M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($2.86M)
May 15, 2023
Q3
2022
Sep 30, 2021
($2.65M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($3.20M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($2.58M)
May 12, 2022
Q3
2021
Sep 30, 2020
($3.26M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($2.89M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($3.10M)
May 17, 2021
Q3
2020
Sep 30, 2019
($2.64M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($2.33M)
Aug 14, 2020